These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 6285444)

  • 1. [Immunological and therapeutic aspects of myasthenia gravis (author's transl)].
    Ghezzi M; Taiuti R; Marconi G
    Riv Patol Nerv Ment; 1981; 102(1):12-28. PubMed ID: 6285444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapies of myasthenia gravis (author's transl)].
    de Crousaz G
    Schweiz Rundsch Med Prax; 1978 Jan; 67(4):113-7. PubMed ID: 202937
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current therapeutic aspects of myasthenia gravis].
    Avilés Mejias S; Ledro Molina D; Garrido Peralta M
    Rev Clin Esp; 1981 Oct; 163(2):139-44. PubMed ID: 6276943
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic strategy in myasthenia gravis].
    Tranchant C
    Rev Neurol (Paris); 2009 Feb; 165(2):149-54. PubMed ID: 19233080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic options in autoimmune myasthenia gravis.
    García-Carrasco M; Escárcega RO; Fuentes-Alexandro S; Riebeling C; Cervera R
    Autoimmun Rev; 2007 Jun; 6(6):373-8. PubMed ID: 17537383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunosuppressive therapy of myasthenia gravis].
    Lechner H; Ott E; Aranibar A
    Nervenarzt; 1976 Jun; 47(6):353-6. PubMed ID: 183158
    [No Abstract]   [Full Text] [Related]  

  • 7. [Myasthenia gravis. Indications, aims and methods of intensive therapy].
    Braschi A; Scherini A; Carbonera D; Mapelli A; Bellinzona G; Bobbio Pallavicini F; Dionigi R; Gasperi A
    Minerva Anestesiol; 1979 Nov; 45(11):871-81. PubMed ID: 548812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune aspects of myasthenia gravis.
    Lisak RP; Levinson AI; Zweiman B
    Concepts Immunopathol; 1985; 2():65-101. PubMed ID: 3916415
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ocular myasthenia: a diagnostic and management challenge--a review].
    Langmann A; Lindner S; Koch M; Diez J
    Klin Monbl Augenheilkd; 2004 Feb; 221(2):77-86. PubMed ID: 14986204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of myasthenia gravis].
    Rilling G; Tettenborn B
    Praxis (Bern 1994); 2001 Aug; 90(33):1350-4. PubMed ID: 11534319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Myasthenia gravis. Recent findings and their therapeutic consequences].
    Thümler R; Haferkamp G
    Dtsch Med Wochenschr; 1979 Oct; 104(40):1415-20. PubMed ID: 227650
    [No Abstract]   [Full Text] [Related]  

  • 12. The treatment of patients with myasthenia gravis.
    Sanders DB; Scoppetta C
    Neurol Clin; 1994 May; 12(2):343-68. PubMed ID: 8041346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The therapy of myasthenia gravis pseudoparalytica].
    Baumgartner RW; Waespe W
    Dtsch Med Wochenschr; 1991 Jan; 116(4):148-54. PubMed ID: 1988277
    [No Abstract]   [Full Text] [Related]  

  • 14. Myasthenia gravis: clinical, immunological, and therapeutic advances.
    Romi F; Gilhus NE; Aarli JA
    Acta Neurol Scand; 2005 Feb; 111(2):134-41. PubMed ID: 15644074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Myasthenia gravis. Immunosuppressive treatment].
    Horn J
    Tidsskr Nor Laegeforen; 1971 Apr; 91(11):821-4. PubMed ID: 4326179
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thymectomy in myasthenia gravis (author's transl)].
    Havia T; Arola M; Inberg MV; Kytömäki O
    Zentralbl Chir; 1976; 101(10):597-601. PubMed ID: 952108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plasma exchange in myasthenia gravis].
    Redeker M; Meyer-Wahl L
    Nervenarzt; 1982 Dec; 53(12):729-32. PubMed ID: 7155236
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunosuppressive therapies in myasthenia gravis.
    Sanders DB; Evoli A
    Autoimmunity; 2010 Aug; 43(5-6):428-35. PubMed ID: 20166870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of myasthenia].
    Goulon M; Estournet B; Gajdos P
    Rev Prat; 1979 Jun; 29(35):2789-99. PubMed ID: 493836
    [No Abstract]   [Full Text] [Related]  

  • 20. Myasthenia gravis: effect of immunoactive therapies.
    Fornádi L; Horváth R; Bárdosi Z; Szobor A
    Acta Med Hung; 1994; 50(1-2):83-92. PubMed ID: 7638045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.